These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10090424)

  • 21. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestogens in the treatment of secondary amenorrhea.
    Simon JA
    J Reprod Med; 1999 Feb; 44(2 Suppl):185-90. PubMed ID: 11392030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?
    Hermsmeyer RK; Thompson TL; Pohost GM; Kaski JC
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):387-95. PubMed ID: 18521110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable contraceptives.
    Toppozada M
    Contracept Deliv Syst; 1982 Apr; 3(2):161-70. PubMed ID: 12338171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for hormone replacement therapy in atherosclerosis prevention.
    Wagner JD
    J Reprod Med; 2000 Mar; 45(3 Suppl):245-58. PubMed ID: 10756506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption and metabolic effects of different types of estrogens and progestogens.
    Lobo RA
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):143-67. PubMed ID: 3306517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on the effect of vaginal administration of micronized progesterone at dysfunctional uterine bleeding in premenopause].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2009; 48(2):3-7. PubMed ID: 20198768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
    Africander D; Verhoog N; Hapgood JP
    Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of progesterone administered by the oral and parenteral routes.
    Stanczyk FZ
    J Reprod Med; 1999 Feb; 44(2 Suppl):141-7. PubMed ID: 11392023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
    J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
    Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-a-month injectable contraceptives.
    Hall PE
    IPPF Med Bull; 1987 Apr; 21(2):1-2. PubMed ID: 12268597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.